Abstract-Following our recent total synthesis of the biologically potent natural products epoxyquinols A and B in racemic form, we have now accomplished the total synthesis of the ())-epoxyquinols A and B, anti-podes of the angiogenesis inhibiting natural products, through a protocol that involves enzymatic desymmetrization of a versatile epoxyquinone derivative, readily available from the Diels-Alder adduct of cyclopentadiene and p-benzoquinone.
Several polyketide derived natural products, bearing the epoxyquinone moiety 1 as the core structure, have been encountered in nature from diverse sources in recent years. 1 Typical examples of such natural products are eupenoxide 2, 1a cycloepoxydon 3 1b and ECH 4 1c among others, and many of them exhibit promising, wide ranging biological activity profiles. Quite naturally, epoxyquinone natural products have evoked considerable attention from the synthetic community over the past few years. 2 In our view, central to the synthetic approach to these natural products is a short, viable access route to the core structure 1 with adequately functionalized side arms. In this context, we have recently disclosed a convenient three step access to the epoxyquinone building block 5 (cf. 1)
3 from the readily available Diels-Alder adduct 6 of cyclopentadiene and p-benzoquinone, Scheme 1. Recognizing the inherent versatility of 5 in the synthesis of epoxyquinone natural products, it was considered imperative to access its derivatives in enantiomerically pure form to harness fully its potential. The symmetrical nature of 5 lends itself amenable to the enzyme mediated 'meso trick'. Indeed, the enzymatic desymmetrization of 5 has now been achieved and in this letter, we demonstrate the preparation of enantiomerically enriched derivatives of 5 and their utility in the total synthesis of ())-epoxyquinols A and B. Scheme 2. 5 The absolute configuration of (+)-7 followed from its conversion to the natural products ())-cycloepoxydon 2i and ())-epoxyquinols A and B (vide infra). Concurrently, meso-diol 5 was converted to the diacetate 8 and desymmetrization employing enzymatic hydrolysis with the same lipase PS 30 (Amano) gave ())-7 ($86% ee) with modest enantioselectivity, Scheme 2. However, with the lipase from Candida rugosa ())-7 was obtained from 8 in high enantiomeric purity ($99% ee). 5 The versatile building block 7 thus became readily accessible in both its enantiomerically enriched forms through enantiodivergency based protocols. We demonstrate here the utility of one of the enantiomers (+)-7 towards the enantioselective synthesis of epoxyquinone natural products ())-epoxyquinol A 9 and ())-epoxyquinol B 10.
Angiogenesis inhibition is emerging as a very promising protocol with therapeutic potential for a variety of disorders ranging from rheumatoid arthritis to cancer 6 and several natural products are being explored as leads for clinical development. 7 In this context, the report of the isolation of two pentaketide derived dimers (+)-epoxyquinol A and (+)-epoxyquinol B from a soil based unknown fungus in 2002, by Japanese scientists, has drawn the immediate attention of synthetic chemists as these unusual natural products exhibited impressive inhibition of angiogenesis. 4 In a short span of one year, three total syntheses of these natural products have appeared in the literature.
3;8 Two of these synthetic accomplishments by the groups of Hayashi 8a and Porco 8b are enantioselective and have led to the natural enantiomers (+)-epoxyquinol A and (+)-epoxyquinol B. On the other hand, our group has reported a synthesis of racemic epoxyquinols A and B. 3 In addition, Hayashi and co-workers have delineated a practical approach to both the enantiomers of epoxyquinols A and B and also disclosed the preparation of some related model compounds.
1c;9
Our synthesis of ())-9 and ())-10, patterned along a biomimetic route, emanated from (+)-7 and a modified and improved variant of our previously described synthesis of racemic 9 and 10 was executed.
3 DIBAL-H reduction of (+)-7 was regio-and stereoselective 10 and directed by the primary hydroxyl group and epoxide oxygen and furnished diol ())-12 through the intermediacy of the aluminium chelate 11, Scheme 3. 11 The diol moiety in 12 was protected as the acetonide ())-13. Reduction of the carbonyl group in 13 with Luche reagent 12 was moderately stereoselective, directed through the coordination of the ceric ion with the epoxy oxygen, to furnish a 7:1 diastereomeric mixture, which on further acetate hydrolysis led to ())-14 and ())-15. The relative stereochemical issue was settled through the X-ray crystal structure determination 13 of the minor diastereomer ())-14, Scheme 3. 11 The primary hydroxyl group in the major epimer ())-15 was chemoselectively oxidized with TEMPO 14 to furnish the aldehyde ())-16.
11
Although hydroxy-aldehyde ())-16 was ready for the installation of the requisite side chain, we found that without the protection of the hydroxyl group, Wittig olefination was capricious. Protection of the hydroxyl group as acetate 17a and Wittig olefination furnished a 1:1 mixture of E and Z isomers 18a in moderate yield. Protection of the hydroxyl group in 16 as TES ether 17b and Wittig olefination gave 18b in improved yield and an altered E:Z ratio of 1:3, Scheme 4. For further efforts, both 18a and 18b were serviceable and after hydroxyl group deprotection and oxidation, diastereomeric (E)-dienone ())-19 and (Z)-dienone ())-20 were readily separated and fully characterized, Scheme 4. and [4+2]-cycloaddition as depicted in Scheme 5. When aldehydes 23 and 24 were left aside neat at ambient temperature, the desired cyclization-cycloaddition occurred readily. In the (E)-series ())-epoxyquinols ())-9 and ())-10 were obtained in a ratio of 3.5:1 from 21, Scheme 5. On the other hand, in the (Z)-series ())-epoxyquinols ())-9 and ())-10 were realized in a ratio of 4:1 in comparable yield. 15 While an hetero-[4+2]cycloaddition through an endo-transition state 25 accounts for the formation of ())-9, an analogous homo-[4+2] cycloaddition through an exo-transition state would result in the formation of ())-10. It is interesting to note that both the diastereomers ())-21 and ())-22 are serviceable and undergo the projected electrocyclizationcycloaddition cascade process with equal felicity and efficiency to furnish the epoxyquinol natural products.
In short, we have outlined a simple, convenient access to enantiomerically enriched, versatile building blocks (+)-7 and ())-7 from the readily available Diels-Alder adduct of cyclopentadiene and p-benzoquinone. The former has been elaborated to ())-epoxyquinols A 9 and B 10, following a biomimetic pathway. . Procedure for enzymatic hydrolysis: A mixture of mesodiacetate 8 (50 mg, 0.187 mmol) and lipase from C. rugosa (Sigma-Aldrich) in distilled water (1.5 mL) was stirred at room temperature for 40 h. The reaction mixture was kept neutral by occasional addition of phosphate buffer (pH 7). After the usual work-up involving extraction with ethyl acetate, the crude product was subjected to column chromatography on silica gel to furnish ())-7 (28 mg, 
